Yoon H, Nakouzi A, Duong V, Hung L, Binh T, Tung N
Med Mycol. 2023; 61(10).
PMID: 37771088
PMC: 10599321.
DOI: 10.1093/mmy/myad102.
Yoon H, Wake R, Nakouzi A, Wang T, Agalliu I, Tiemessen C
Clin Infect Dis. 2022; 76(4):649-657.
PMID: 35915964
PMC: 10226730.
DOI: 10.1093/cid/ciac633.
Yoon H, Nakouzi A, Pappas P, Hemmige V, Pirofski L
Open Forum Infect Dis. 2022; 9(7):ofac211.
PMID: 35794949
PMC: 9253883.
DOI: 10.1093/ofid/ofac211.
Gressler A, Volke D, Firacative C, Schnabel C, Muller U, Krizsan A
Front Immunol. 2021; 12:709695.
PMID: 34367172
PMC: 8342929.
DOI: 10.3389/fimmu.2021.709695.
Trevijano-Contador N, Pirofski L
Curr Trop Med Rep. 2019; 6(2):50-54.
PMID: 31134140
PMC: 6533914.
DOI: 10.1007/s40475-019-00174-1.
Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia.
Hlupeni A, Nakouzi A, Wang T, Boyd K, Makadzange T, Ndhlovu C
Open Forum Infect Dis. 2019; 6(1):ofy333.
PMID: 30648127
PMC: 6329905.
DOI: 10.1093/ofid/ofy333.
Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome.
Yoon H, Nakouzi A, Chang C, Kuniholm M, Carreno L, Wang T
J Infect Dis. 2018; 219(3):420-428.
PMID: 30010905
PMC: 6325352.
DOI: 10.1093/infdis/jiy447.
Antibody and B Cell Subset Perturbations in Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis.
Rohatgi S, Nakouzi A, Carreno L, Slosar-Cheah M, Kuniholm M, Wang T
Open Forum Infect Dis. 2018; 5(1):ofx255.
PMID: 29354657
PMC: 5767948.
DOI: 10.1093/ofid/ofx255.
Host immunity to Cryptococcus neoformans.
Rohatgi S, Pirofski L
Future Microbiol. 2015; 10(4):565-81.
PMID: 25865194
PMC: 4523559.
DOI: 10.2217/fmb.14.132.
Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.
Rohatgi S, Gohil S, Kuniholm M, Schultz H, Dufaud C, Armour K
mBio. 2013; 4(5):e00573-13.
PMID: 23982074
PMC: 3760251.
DOI: 10.1128/mBio.00573-13.
Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.
Rohatgi S, Pirofski L
J Immunol. 2012; 189(12):5820-30.
PMID: 23175699
PMC: 3518565.
DOI: 10.4049/jimmunol.1201514.
Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.
Casadevall A, Pirofski L
Cell Host Microbe. 2012; 11(5):447-56.
PMID: 22607798
PMC: 3360875.
DOI: 10.1016/j.chom.2012.04.004.
The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.
Subramaniam K, Datta K, Quintero E, Manix C, Marks M, Pirofski L
J Immunol. 2010; 184(10):5755-67.
PMID: 20404271
PMC: 2885446.
DOI: 10.4049/jimmunol.0901638.
Cryptococcal interactions with the host immune system.
Voelz K, May R
Eukaryot Cell. 2010; 9(6):835-46.
PMID: 20382758
PMC: 2901644.
DOI: 10.1128/EC.00039-10.
Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans.
Subramaniam K, Datta K, Marks M, Pirofski L
Infect Immun. 2009; 78(1):441-52.
PMID: 19901068
PMC: 2798234.
DOI: 10.1128/IAI.00506-09.
IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status.
Subramaniam K, Metzger B, Hanau L, Guh A, Rucker L, Badri S
J Infect Dis. 2009; 200(2):244-51.
PMID: 19527168
PMC: 2805277.
DOI: 10.1086/599318.
Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.
Saha D, Xess I, Zeng W, Goldman D
Med Mycol. 2008; 46(5):457-63.
PMID: 18608912
PMC: 4100580.
DOI: 10.1080/13693780801961345.
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.
Singh N, Alexander B, Lortholary O, Dromer F, Gupta K, John G
J Infect Dis. 2007; 195(5):756-64.
PMID: 17262720
PMC: 2746485.
DOI: 10.1086/511438.
Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.
Jalali Z, Ng L, Singh N, Pirofski L
Clin Vaccine Immunol. 2006; 13(7):740-6.
PMID: 16829610
PMC: 1489574.
DOI: 10.1128/CVI.00139-06.
Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.
Pirofski L
Infect Immun. 2006; 74(6):3079-84.
PMID: 16714535
PMC: 1479240.
DOI: 10.1128/IAI.00431-06.